551.47
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché UTHR Giù?
Forum
Previsione
Frazionamento azionario
United Therapeutics Corp Borsa (UTHR) Ultime notizie
Martine Rothblatt, United Therapeutics CEO, sells $5.1m in stock - Investing.com UK
United Therapeutics Corporation (UTHR) Stock Analysis: Exploring a 21.85% Upside Potential - DirectorsTalk Interviews
MannKind Stock Plummets After Partner United Therapeutics Unveils New ‘Category Killer Product’ - Stocktwits
United Therapeutics CFO Edgemond sells $5.49m in company stock By Investing.com - Investing.com Nigeria
United Therapeutics CFO Edgemond sells $5.49m in company stock - Investing.com
Neuroblastoma Market Gains Momentum with Expanding Pipeline and Investment Potential by 2034 – DelveInsight | Y-mAbs Therapeutics, United Therapeutics Corp, EUSA Pharma, Clarity Pharma, Eli Lilly - Barchart.com
Martine Rothblatt, United Therapeutics chairperson & CEO, sells $5.2m in stock - Investing.com
iShares U.S. Pharmaceuticals ETF Tops Simplify Health Care ETF Returns - The Motley Fool
United Therapeutics CEO Rothblatt sells $5.2m in shares By Investing.com - Investing.com Canada
United Therapeutics CEO Rothblatt sells $5.2m in shares - Investing.com
United Therapeutics CFO James Edgemond sells $5.48m in stock - Investing.com
United Therapeutics CFO James Edgemond sells $5.48m in stock By Investing.com - Investing.com Australia
Goodwin Advises Ascidian Therapeutics On A Global Research Collaboration With Eli Lilly For Up To $1.9 Billion - Mondaq
Martine Rothblatt, United Therapeutics CEO, sells $5.2m in stock By Investing.com - Investing.com South Africa
Martine Rothblatt, United Therapeutics CEO, sells $5.2m in stock - Investing.com
United Therapeutics Corporation (UTHR) Stock Analysis: Investor Outlook on Robust Growth Potential with 20.98% Upside - DirectorsTalk Interviews
United Therapeutics CEO Rothblatt sells $5.47m in stock - Investing.com
UTHRUnited Therapeutics Corp Stock Price and Quote - Finviz
Why Is United Therapeutics (UTHR) Down 3.8% Since Last Earnings Report? - Yahoo Finance
How The Story Around United Therapeutics (UTHR) Is Shifting On Trials Pricing And Valuation - Yahoo Finance
MannKind develops inhaled ralinepag formulation for United Therapeutics - Investing.com
United Therapeutics EVP Mahon sells $4.54 million in stock - Investing.com UK
United Therapeutics Q1 2026 slides: IPF breakthrough offsets revenue miss - Investing.com
MannKind stock surges on United Therapeutics partnership deal - Investing.com
United Therapeutics EVP Mahon sells $4.54 million in stock By Investing.com - Investing.com Australia
United Therapeutics stock hits all-time high at 608.87 USD - Investing.com
UTHR Technical Analysis & Stock Price Forecast - Intellectia AI
UTHR Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Tectonic Therapeutic Stock Climbs as Broader Market Sinks - Bez Kabli
Xenotransplantation Explained: How Animal Organs Could Transform Medicine - News-Medical
Acute Respiratory Distress Syndrome Market to Grow - One News Page
Rothblatt (United Therapeutics) sells $5.3m in UTHR stock - Investing.com
Perspective Therapeutics Expands Therapeutic Focus Areas; First Patient Dosed with [212Pb]VMT-α-NET in the Meningioma Cohort of a Phase 1/2a Study - The Manila Times
United Therapeutics CFO James Edgemond sells $5.48m in shares - Investing.com UK
United Therapeutics CEO Rothblatt sells $863,947 in stock By Investing.com - Investing.com Nigeria
United Therapeutics CEO Martine Rothblatt sells $5.2m in company stock - Investing.com Nigeria
United Therapeutics CFO James Edgemond sells $5.48m in shares By Investing.com - Investing.com India
United Therapeutics CEO Rothblatt sells $863,947 in stock - Investing.com
United Therapeutics CEO Martine Rothblatt sells $5.2m in company stock By Investing.com - Investing.com South Africa
Vanguard (VHT) Vs. Simplify (PINK): Which Healthcare ETF Is the Better Buy for Investors? - The Motley Fool
Simplify Health Care ETF (PINK) vs. Vanguard Health Care ETF (VHT): A Detailed ComparisonNews and Statistics - IndexBox
Liquidia Sinks 5% After Recent Rally - Bez Kabli
United Therapeutics Corporation (UTHR) Stock Analysis: Exploring a 19.47% Potential Upside - DirectorsTalk Interviews
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):